This application seeks continued support for a longstanding and successful Cancer Biology Training Program (CBTP) at the Eppley Institute, an academic unit of the University of Nebraska Medical Center (UNMC), with a sole focus on basic, translational and clinical cancer research. The Eppley Institute is a major component of the NCI-designated Fred & Pamela Buffett Cancer Center, which is one of only two NCI-designated cancer centers in a five state region from North Dakota to Texas. As such, the Eppley Institute and the CBTP play an important regional role in training future basic and clinical scientists for a career in cancer research. Significant growth of the CBTP over the past five years reflects a major expansion of the Cancer Center, with an increase in state-of-the-art research space, a growing faculty, and a robust research base. The NCI Training Grant has been a major catalyst for the success of the CBTP, which attracts a large national pool of predoctoral trainees and currently has 102 students in training. Thirty three CBTP mentors have a wide variety of expertise in cutting-edge basic, translational and clinical cancer research and a strong track record of mentoring. Translational research by CBTP faculty in biomarker discovery and therapeutic development for pancreatic/GI cancer is internationally recognized, and a Rapid Autopsy/Organ Harvest Program provides a unique collection of specimens for studies on pancreatic cancer. Previous success of the CBTP is reflected in the strong publication record of our trainees, low attrition rates, the accomplishments of trainees who have completed the program, and the growing participation of minorities in our educational mission. In this renewal application, our goal is to build on past successes with major new initiatives that highlight contemporary and emerging trends in cancer research, and keep pace with modern developments. Major goals include (1) extensive restructuring of the curriculum, with addition of seven new courses addressing key areas such as bioinformatics, biostatistics, and translational/clinical training as well as grantsmanship and scientific writing; (2) invigorating te faculty through addition of highly accomplished junior investigators; (3) an aggressive mentoring plan that helps students identify and accomplish their career goals; (4) new research-related training opportunities, including off-site training experiences; and (5) strong Institutional commitment. Through didactic coursework, high quality research, and hands-on exposure to translational/clinical activities, our new curriculum challenges trainees to consider how their research may be translated into improvements in the diagnosis and treatment of cancer. Students who complete the CBTP will have the life-long skills to contribute to the management of cancer in a meaningful way. Continued Training Grant support is crucial to sustaining the advances in Program metrics, enabling further enrichment of the training experience, as well as ensuring the quality and diversity of CBTP trainees.

Public Health Relevance

Predoctoral training in cancer biology is directly relevant to public health. Understanding, preventing, and treating cancer remains a national priority. The mission of the CBTP addresses a critical need to train the next generation of cancer researchers in a large region of the United States, in order to provide a foundation for tomorrow's clinical advances in the treatment and management of this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009476-26
Application #
9302681
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Perkins, Susan N
Project Start
1997-08-22
Project End
2020-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
26
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Das, Binita; Neilsen, Beth K; Fisher, Kurt W et al. (2018) A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Sci Rep 8:3770
Contreras, Jacob I; Robb, Caroline M; King, Hannah M et al. (2018) Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. ACS Chem Biol 13:1148-1152
Neilsen, Beth K; Chakraborty, Binita; McCall, Jamie L et al. (2018) WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage. BMC Cancer 18:673
Wipfler, Kristin; Cornish, Adam S; Guda, Chittibabu (2018) Comparative molecular characterization of typical and exceptional responders in glioblastoma. Oncotarget 9:28421-28433
Cruz, Eric; Kumar, Sushil; Yuan, Li et al. (2018) Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis. PLoS One 13:e0191696
Banerjee, Kasturi; Kumar, Sushil; Ross, Kathleen A et al. (2018) Emerging trends in the immunotherapy of pancreatic cancer. Cancer Lett 417:35-46
Barbari, Stephanie R; Kane, Daniel P; Moore, Elizabeth A et al. (2018) Functional Analysis of Cancer-Associated DNA Polymerase ? Variants in Saccharomyces cerevisiae. G3 (Bethesda) 8:1019-1029
Ingersoll, Matthew A; Chou, Yu-Wei; Lin, Jamie S et al. (2018) p66Shc regulates migration of castration-resistant prostate cancer cells. Cell Signal 46:1-14
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136

Showing the most recent 10 out of 217 publications